Domestic market pricing and purchasing guide for DaliRasen tablets in various regions
Daridorexantas a new generation of orexin receptor antagonist (DORA), has been approved in the European and American markets for the treatment of insomnia, especially for patients with difficulty falling asleep and maintaining sleep. Due to its unique mechanism of action, the drug has shown good safety and tolerability in clinical applications and has received widespread attention. However, DaliRasen has not yet been officially launched in China, so patients cannot purchase the drug directly through formal domestic channels.
In the international market, the main source of supply of DaliRasen is Europe. The existing version is usually the original drug, and the specification is generally 50mg × 30 tablets. Since there are no generic drugs on the market yet, their prices are relatively high, usually around RMB 2,000-3,000, and may fluctuate due to exchange rates, import costs and supply conditions. For domestic patients, if they need it, they can obtain it through legal overseas drug purchasing channels, such as cross-border e-commerce, overseas pharmacies or drug purchasing services from international medical institutions. However, when choosing a drug purchasing channel, you need to pay special attention to the reliability of the source of the drug and avoid purchasing fake drugs or drugs from informal channels to ensure drug safety.
Before purchasing, patients should consult a professional doctor to evaluate their suitability and choose the appropriate dosage according to the doctor's advice. The recommended usage of DaliRazen is once nightly at a dose of 25 mg or 50 mg, 30 minutes before planned sleep time, and ensuring at least 7 hours of sleep. If taken with or after meals, it may cause a delay in falling asleep. Therefore, patients should follow the instructions carefully when using this drug to get the best results. In addition, because Dalilaysan is a newer insomnia treatment drug, its interaction with other drugs still needs further study. Patients should consult a doctor before taking it and avoid using it at the same time with other drugs that affect the central nervous system.
Reference materials:https://www.quviviq.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)